Investor Day

Mission Produce aims to double sales by 2035, but can its massive Calavo Growers integration and shift to prepared foods survive commodity market volatility?

As AI demand surges, AIB faces the ultimate test: funding and delivering a massive 50 MW data center without diluting existing shareholders.

As CarMax prepares to unveil its multi-year financial framework, rising loan delinquencies and digital rivals test the limits of its omnichannel strategy.

As ADX heads to New York, Abu Dhabi pitches resilient dividends and market reforms to lure US institutional capital away from regional rivals.

With standard-of-care avacopan facing global regulatory withdrawal, InflaRx is stepping into the void. A strategic look at the upcoming Capital Markets Day and the mechanics of clinical resilience.

Ahead of its 2026 Investor Day, Minerals Technologies is proving that the future of mining lies not in extraction, but in engineered crystal formulations.

The IT distribution giant bets its future on an AI-powered platform, Xvantage™, promising radical efficiency and ambitious profit growth. But can it deliver?

As Norsk Hydro prepares for its London Investor Day, it must navigate market volatility and operational hurdles while championing its ambitious green aluminum strategy.

With FDA approval for its RefluxStop® device, Implantica challenges the GERD treatment status quo, promising better outcomes without debilitating side effects.

With a new cancer drug showing promise but cash reserves dwindling, Citius Pharma's CEO faces a critical test: convincing investors the pipeline is worth the risk.

With new products like Nexis and SST on the horizon and a renewed focus on storage, SolarEdge's upcoming Investor Day is a critical test of its growth strategy.

Niagen Bioscience heads to a key investor conference. Can its CFO translate the complex science of healthy aging into a compelling story for market growth?

With a new CEO at the helm and its recent blockbuster acquisition of Calavo Growers completed, Mission Produce's upcoming Investor Day will define its future in a volatile market.

As dental giant Envista preps its September investor summit, it must prove its operational engine and digital pivot can convert recent financial wins into lasting value.

As the world's largest McDonald's franchisee preps for its key Investor Day, it's betting its future on a high-tech strategy to conquer Latin America.

With lifespans rising, a new financial frontier is emerging. Abacus Global Management is turning longevity into a tradable asset. What does this mean for our future?

As Valmont prepares its Q2 report, investors watch a tale of two markets: a surging infrastructure segment and a slumping agricultural arm. Which will define its future?

As Pure Cycle preps for its Investor Day, a closer look reveals a unique strategy where water rights fuel land development and create a recurring revenue engine.

As Standex CEO David Dunbar prepares for the CJS New Ideas Conference, we analyze the firm's strategic pivot toward high-growth tech and what's at stake.

With its U.S. launch underway, Nyxoah is betting its innovative Genio system can unseat an industry giant. But can it chart a path to profitability?